Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data OMEROS CORP files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
41.6
64.8
29.9
112
73.8
Cost of revenue
1.41
1.08
0.51
0.87
0.9
Gross profit
40.2
63.7
29.4
111
72.9
Research and development
50.7
55.6
89.9
106
108
119
113
115
120
81.3
Selling, general and administrative
54.8
50.7
49.7
47.4
41.5
General and administrative
43.8
52
51.7
39.7
49.3
54.8
50.7
Operating expenses
95.9
109
142
Operating income
-54.3
-43.9
-112
-146
-157
-174
-163
-165
-167
-123
Interest expense
7.82
11
16.3
22.7
26.8
19.7
22.7
30.8
24.7
-0.96
Interest income
2.2
14.7
8.4
2.3
Other non-operating income
0.95
1.44
1.78
1.55
0.65
1.74
Pre-tax income
-66.7
-53.5
-140
-167
-196
-192
-182
-175
-180
-2.8
Income tax
0
0
-12.9
-19.8
-23.3
0
0
0
2.31
2.01
Income from continuing operations
-147
-173
-192
-182
-175
-183
-4.81
Net income
-66.7
-53.5
-127
-84.5
-138
194
47.4
-118
-157
-3.35
EBITDA
-54
-43.3
-111
-144
-155
-172
-162
-164
-166
-122
EPS, basic
-1.65
-1.17
-2.61
-1.71
-2.41
3.12
0.76
-1.88
-2.70
-0.05
EPS, diluted
-1.65
-1.17
-2.61
-1.71
-2.41
3.12
0.76
-1.88
-2.70
-0.05
Shares, basic (weighted)
40.4
45.5
48.6
49.5
57.2
62.3
62.7
62.7
58.2
63.5
Shares, diluted (weighted)
40.4
45.5
48.6
49.5
57.2
62.3
62.7
62.7
58.2
63.5
Balance sheet
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
2.22
3.39
5.86
3.08
10.5
101
11
7.11
3.4
9.66
Short-term investments
54.6
57.7
124
56.5
184
165
86.7
162
Receivables
12
17.1
22.8
35.2
3.84
38.2
213
8.1
7.74
0
Inventory
1.13
0.44
0.09
1.15
1.36
0
Other current assets
1.77
7.04
6.46
6.63
10.5
8.22
6.3
8.58
7.17
7.6
Total current assets
60.3
108
89.9
104
151
248
443
218
134
216
Property, plant and equipment
1.18
2.12
3.85
3.83
2.55
1.73
1.49
1.95
2.68
1.77
Lease right-of-use assets
0
27.1
25.5
28.3
21.8
18.6
15
10.7
Other non-current assets
0
Total assets
67.3
116
95.9
137
181
419
591
378
277
326
Accounts payable
2.52
6.69
6.28
5.33
4.2
13.4
5.99
7.71
5.91
4.76
Accrued liabilities
13.4
19.1
30.2
46.6
28.8
33.1
30.6
31.9
26
29.4
Deferred revenue
0.18
2.47
Short-term debt
0.2
0.49
0.89
Total current liabilities
16.1
26.3
37.4
55.5
36.7
51.8
136
53.3
79.5
78.1
Long-term debt
79.5
84.1
149
158
236
313
221
213
97.2
51.4
Lease liabilities
30.8
28
28.8
22
17.4
12.2
6.52
Total liabilities
105
119
196
246
302
395
505
403
460
447
Total debt
80.5
83.8
0.89
158
236
313
315
213
165
87.9
Paid-in capital
432
520
549
625
751
706
721
728
727
792
Retained earnings
-470
-523
-650
-735
-873
-683
-636
-754
-910
-914
Shareholders' equity
-37.4
-2.81
-100
-109
-121
23.8
85.7
-25
-183
-121
Total equity
-37.4
-2.81
-100
-109
-121
23.8
85.7
-25
-183
-121
Total liabilities and equity
67.3
116
95.9
137
181
419
591
378
277
326
Shares outstanding
43.8
48.2
49
54.2
61.7
62.6
62.8
61.1
58
71.7
Cash flow statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
-66.7
-53.5
-127
-84.5
-138
194
47.4
-118
-157
-3.35
Depreciation and amortization
0.3
0.55
0.96
1.79
1.62
1.39
0.95
0.92
0.95
0.96
Stock-based compensation
13.6
12.7
11.7
13.8
14.9
17.6
14.1
11.7
10.5
8.19
Deferred income tax
0
0
-12.9
-19.8
-23.3
0
0
0
0
0
Change in receivables
-5.52
-5.11
-5.67
-12.4
31.3
-34.3
-175
205
0.36
-3.18
Change in inventory
-0.66
0.69
0.36
-1.06
-0.21
Change in payables
-0.42
9.52
10.1
13.3
-19.7
14.6
-10.7
4.68
-5.24
4.58
Cash from operations
-51.5
-36.2
-104
-60.1
-100
-110
-86.5
74.7
-149
-116
Capital expenditures
-0.13
-0.35
-0.57
-0.33
-0.28
-0.28
-0.11
-0.43
-0.17
-0.07
Purchases of investments
-65.3
-68.8
-58.2
-133
-32
-429
-1,019
-987
-185
Sales and maturities of investments
28.1
94.5
55.2
66.4
100
302
1,046
1,070
110
Cash from investing
-16.3
-37.6
25.2
-3.4
-67
194
-128
27.5
82.2
165
Debt issued
100
0
44.6
Stock issued
38
63.7
0
54.2
93.7
0.42
0.15
0.55
7.65
Share buybacks
0
0
-4.65
-11.9
0
Cash from financing
68.7
75
81.1
60.7
175
6.32
124
-106
62.9
-42.2
Net change in cash
0.86
1.17
2.47
-2.78
7.42
90.3
-89.8
-3.9
-3.71
6.26
Free cash flow
-51.6
-36.6
-104
-60.4
-100
-110
-86.6
74.3
-149
-116
Interest paid
5.29
6.9
8.9
13.5
11.6
17.9
19.2
29.9
35.7
35.4
Income taxes paid
0.08
3.29
0.17
0.15
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $20.08 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Return on assets (ROA)
43.5%
Net income / average total assets.
Growth
Metric
Value
How it is calculated
Total assets growth, 1y
17.5%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
-18.0%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
12.5%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
9.2%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
0.4%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
2.1%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
1.95x
Current assets / current liabilities.
Quick ratio
1.51x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
1.39x
(Cash + short-term investments) / current liabilities.
Free cash flow / net income, when net income is positive.
Per share
Metric
Value
How it is calculated
EPS, diluted
$1.39
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
FCF per share
-$0.77
Free cash flow / diluted weighted shares.
Operating cash flow per share
-$0.77
Cash from operations / diluted weighted shares.
Book value per share
-$0.71
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/E
11.6x
Market cap / net income. Only when net income is positive.
FCF yield
-4.7%
Free cash flow / market cap.
Earnings yield
8.6%
Net income / market cap (the inverse of P/E).
Shareholder yield
0.7%
(Dividends paid + share buybacks) / market cap.
Was OMEROS CORP profitable in fiscal 2025?
No. It reported a net loss of $3.4M.
How much free cash flow did OMEROS CORP generate in fiscal 2025?
Cash from operations of $116.1M minus capital expenditures of $65.0K left free cash flow of -$116.2M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.